Literature DB >> 31268604

TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.

Parash Parajuli1, Purba Singh2, Zhe Wang2, Lianna Li2, Sailaja Eragamreddi2, Seval Ozkan2, Olivier Ferrigno3, Celine Prunier3, Mohammed S Razzaque4, Keli Xu2, Azeddine Atfi1,3.   

Abstract

A prominent function of TGIF1 is suppression of transforming growth factor beta (TGF-β) signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal adenocarcinoma (PDAC), as exemplified by the frequent loss of the tumor suppressor gene SMAD4 in this malignancy. Surprisingly, we found that genetic inactivation of Tgif1 in the context of oncogenic Kras, KrasG12D , culminated in the development of highly aggressive and metastatic PDAC despite de-repressing TGF-β signaling. Mechanistic experiments show that TGIF1 associates with Twist1 and inhibits Twist1 expression and activity, and this function is suppressed in the vast majority of human PDACs by KrasG12D /MAPK-mediated TGIF1 phosphorylation. Ablating Twist1 in KrasG12D ;Tgif1KO mice completely blunted PDAC formation, providing the proof-of-principle that TGIF1 restrains KrasG12D -driven PDAC through its ability to antagonize Twist1. Collectively, these findings pinpoint TGIF1 as a potential tumor suppressor in PDAC and further suggest that sustained activation of TGF-β signaling might act to accelerate PDAC progression rather than to suppress its initiation.
© 2019 The Authors.

Entities:  

Keywords:  TGF-β signaling; TGIF1; Twist1; oncogenic Kras; pancreatic ductal adenocarcinoma

Mesh:

Substances:

Year:  2019        PMID: 31268604      PMCID: PMC6601038          DOI: 10.15252/embj.2018101067

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  61 in total

1.  TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis.

Authors:  Ming-Zhu Zhang; Olivier Ferrigno; Zhe Wang; Mutsuko Ohnishi; Céline Prunier; Laurence Levy; Mohammed Razzaque; Williams C Horne; Damian Romero; Guri Tzivion; Frédéric Colland; Roland Baron; Azeddine Atfi
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

2.  A mechanism for mutational inactivation of the homeodomain protein TGIF in holoprosencephaly.

Authors:  Nathalie Ferrand; Christine Demange; Céline Prunier; Su Ryeon Seo; Azeddine Atfi
Journal:  FASEB J       Date:  2006-12-08       Impact factor: 5.191

3.  Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling.

Authors:  Su Ryeon Seo; Nathalie Ferrand; Nourdine Faresse; Céline Prunier; Lucile Abécassis; Marcia Pessah; Marie-Francoise Bourgeade; Azeddine Atfi
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

4.  Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis.

Authors:  Céline Prunier; Ming-Zhu Zhang; Santosh Kumar; Laurence Levy; Olivier Ferrigno; Guri Tzivion; Azeddine Atfi
Journal:  Cell Rep       Date:  2015-02-12       Impact factor: 9.423

Review 5.  The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting.

Authors:  Scott E Kern; Chanjuan Shi; Ralph H Hruban
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

6.  Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.

Authors:  R S Lo; D Wotton; J Massagué
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

7.  MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice.

Authors:  Meredith A Collins; Wei Yan; Judith S Sebolt-Leopold; Marina Pasca di Magliano
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

8.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Authors:  Nabeel Bardeesy; Andrew J Aguirre; Gerald C Chu; Kuang-Hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark S Redston; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Loss of Tgif function causes holoprosencephaly by disrupting the SHH signaling pathway.

Authors:  Kenichiro Taniguchi; Anoush E Anderson; Ann E Sutherland; David Wotton
Journal:  PLoS Genet       Date:  2012-02-23       Impact factor: 5.917

10.  Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer.

Authors:  Ann F Cheung; Michel J P Dupage; H Katie Dong; Jianzhu Chen; Tyler Jacks
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

View more
  7 in total

1.  Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1.

Authors:  Yang Yang; Yuan Zhang; Zongxiang Lin; Kai Wu; Zhanfeng He; Dengyan Zhu; Jia Zhao; Chunyang Zhang; Yuxia Fan
Journal:  Cancer Cell Int       Date:  2022-05-16       Impact factor: 6.429

Review 2.  Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.

Authors:  Zhao Huang; Zhe Zhang; Chengwei Zhou; Lin Liu; Canhua Huang
Journal:  MedComm (2020)       Date:  2022-05-18

3.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

4.  Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.

Authors:  Christian T Fontan; Dipon Das; Molly L Bristol; Claire D James; Xu Wang; Hannah Lohner; Azeddine Atfi; Iain M Morgan
Journal:  mSphere       Date:  2020-12-09       Impact factor: 4.389

5.  Structural Insight into the Binding of TGIF1 to SIN3A PAH2 Domain through a C-Terminal Amphipathic Helix.

Authors:  Xiaoling He; Yao Nie; Heng Zhou; Rui Hu; Ying Li; Ting He; Jiang Zhu; Yunhuang Yang; Maili Liu
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

6.  Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.

Authors:  Hao Wang; Dongyue Zhang; Xiaoxi Cui; Yibo Dai; Chenchen Wang; Wenli Feng; Xiaoqian Lv; Yifei Li; Lina Wang; Yongxin Ru; Yingchi Zhang; Qian Ren; Guoguang Zheng
Journal:  Oncogene       Date:  2022-03-07       Impact factor: 8.756

7.  TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β‑catenin and Akt/mTOR signaling pathways.

Authors:  Lingling Kong; Yang Yu; Hui Guan; Liyang Jiang; Fenghao Sun; Xiaolin Li; Wei Huang; Baosheng Li
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.